The only thing I recall that was a tiny issue was the QT interval , If I am not mistaken Pima caused a slight delay, ie prolongation, its been so long I dont even remember what the final result was. Geez.
well give me address to submit a poem to LZ site. I will contact you. Your site uses Outlook, and believe it or not I don't have it.
I know i could be totally wrong too-this could be a good trade today, but the pressures will come to light as time goes on.Good luck.
My take is sell the news at some point, maybe tomorrow. Generic drug maker with a specialty delivery, - reminds me of MNKD. Low float making this move . Note there is a lot of generic competition that will pressure the sales and I am concerned the drug insurance Payers will block most sales at the pharmacy window with their criteria and Brand Name Co-Pays, or they will either not pay for the Rx, no matter how many Rx are written by doc's. Good luck.
Ah...I doubt it. first of all presently (that means now) physicians can write all the prescriptions for Afrezza they please, but they didn't. Also, Insurance Drug Payers could pay for it because its such a great drug...but they don't. Patients can pay the brand name price (expensive compared to generics) all day long...but they won't either.
Well, I consider MNKD's attempt a failure, so thats twice...Ask Sanofi if you don't believe me. I find it hard to believe your doc never heard of Afrezza. I am sure he is a good doc, but that it is odd. Is he private practice or HMO ? is he a specialist? he certainly is not an Endocrinologist thats for sure. I mean most Internist , Family Practice, General Practice, ie Primary Care providers know that Inhaled insulin has been tried before and failed, but the first time it failed has been a few years.
Some things you didn't consider, There is only about 30 mil diabetics in the USA. And it really doesn't matter if a patient can afford to pay for the drug or not, its what the doc prescribes that counts. And few doc's will recommend inhaled insulin. I mean you think because a patient says "I don't like needles " they will all get an inhaler...if that's what you think you are clueless. As a physician, knowing full well inhaled insulin has now failed twice, I would not recommend it and wouldn't even mention it unless a patient brought it up. There are just too many other options. Most medication(Probably all) insurance payers- your health insurance - will only cover it for very few patients with very specific criteria. The Payers will charge a Brand Name Co-Pay for every 1 month supply, few patients want to even pay that when they could pay a very low Co-Pay for generic meds. Also all physicians who treat Diabetes have programs in place to start patients on insulin and follow their progress. Many use those insulin Pens. Patients love their Pens that have very tiny needles, minimal discomfort for a few seconds. The pens have a high brand loyalty. Also any drugs in the EU will be subsidized - probably about a 30% discount.
She is really odd, She announces she wants to "cure" cancer one day but then bad mouths biotech the next. Oh i get it, she wants a cure for free...But I would rather have her in the race for the Dem's than that socialist Sanders.
I presume all the QA issues have been cleaned up otherwise the FDA would not have accepted the NDA aye. This drop has created a huge opportunity for those who can white knuckle it for a few months as China & Oil take the hit.